Some studies have demonstrated that Gremlin 1 is overexpressed in some human cancers including colorectal cancer, pancreatic cancer, lung cancer, ovary cancer, renal cancer, breast cancer, cervical cancer, glioblastoma, hepatocellular carcinoma and diffuse B-cell lymphoma33, 42. Here, GREM1 is linked to renal carcinoma.